Cardinal Health, Inc.: Climate Transition Plan Reporting
WHEREAS: The increasing rate and number of climate related disasters affecting society is causing alarms to be raised globally, making the corporate sector’s contribution to climate mitigation a significant policy issue.
In addition to environmental and social harms, climate change is creating systemic risks to the economy. The Commodity Futures Trading Commission last year underscored that climate change could impair the productive capacity of the U.S. economy.
Shareholders are increasingly concerned about material climate risk to their companies and to their portfolios and seek clear and consistent disclosures from the companies in which they invest, including credible climate transition plans. BlackRock’s CEO notes that investment flows into “sustainable” and climate aligned assets will drive long term outperformance and that companies should disclose plans for how their business model will be compatible with a net zero economy.
In response to material climate risk, the Climate Action 100+ initiative (CA100+), a coalition of more than 575 investors with over $54 trillion in assets, issued a Net Zero Benchmark (Benchmark) outlining metrics that create climate accountability for companies and transparency for shareholders. Indicators 1 through 5 of the Benchmark seek reporting on companies’ net zero emissions ambitions; short, medium and long term greenhouse gas (GHG) reductions goals; and strategic actions planned to achieve decarbonization targets.
Cardinal Health is a distributor of pharmaceuticals and manufacturer of medical products, serving more than 3.4 million patients in over 40 countries. Our company discloses its GHG emissions and is undertaking certain energy efficiency activities, including optimizing HVAC equipment and upgrading lighting technology. These actions are a good first step, but Cardinal Health has not set targets to reduce GHG emissions across its entire enterprise or put forth a set of actions to achieve Paris-aligned GHG emissions reductions. By setting and disclosing GHG emissions reduction targets, including net zero ambitions, reporting a clear climate transition plan, and demonstrating progress toward achieving them, Cardinal Health can provide investors with assurance that management is reducing its climate contribution and addressing risks associated with climate change.
BE IT RESOLVED: Shareholders request that Cardinal Health issue a report within a year, and annually thereafter, at reasonable expense and excluding confidential information, that discloses short, medium, and long term greenhouse gas targets aligned with the Paris Agreement’s goal of maintaining global temperature rise well below 2 degrees Celsius, and progress made in achieving these goals. This reporting should cover the company’s operational and product related emissions.
SUPPORTING STATEMENT: Proponents suggest, at Board and Company discretion, the report describe:
The Company’s climate transition plan for achieving its GHG reduction goals over time;
How the company’s capital allocation plans align with the Company’s climate transition plan, where relevant;
Other information the Board deems appropriate.
Resolution Details
Company: Cardinal Health, Inc.
Lead Filers:
As You Sow
Year: 2021
Filing Date:
May 2021
Initiative(s): Say On Climate
Status: Wtihdrawn